1 |
(18)f-fdg |
- |
- |
- |
- |
085 1件: 85 💬 |
2 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
3 |
3-[4-(1h-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(n-butyloxylcarbamate)-sulphonamide] sodium salt |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
4 |
534-1508 |
- |
- |
- |
- |
085 1件: 85 💬 |
5 |
68ga-bmv101 |
- |
- |
- |
- |
085 1件: 85 💬 |
6 |
[18f]-fba-a20fmdv2 |
- |
- |
- |
- |
085 1件: 85 💬 |
7 |
[18f]fp-r01-mg-f2 |
- |
- |
- |
- |
085 2件: 85, 94 💬 |
8 |
[68ga]cbp8 |
- |
- |
- |
- |
085 1件: 85 💬 |
9 |
[bg00011] |
- |
- |
- |
- |
085 1件: 85 💬 |
10 |
[rvt-1601 (in precedenza pa101b)] |
- |
- |
- |
- |
085 1件: 85 💬 |
11 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
12 |
Acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 16件: 6 , 13, 19, 20, 34, 49, 51, 58, 85, 94, 111, 164, 193, 233, 298, 299 💬 |
13 |
Acetylcysteine effervescent tablets |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
14 |
Act-064992 |
- |
- |
- |
- |
051 5件: 51, 85, 86, 88, 210 💬 |
15 |
Act-064992 (macitentan) |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
16 |
Adult human mesenchymal stem cells |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
085 2件: 85, 96 💬 |
17 |
Aerosol interferon-gamma |
- |
- |
- |
- |
085 1件: 85 💬 |
18 |
Air |
- |
- |
- |
- |
003 7件: 3 , 51, 58, 85, 97, 193, 299 💬 |
19 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
20 |
Allogeneic adult human mesenchymal stem cells (hmscs) |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
085 1件: 85 💬 |
21 |
Ambrisentan |
Ambrisentan |
1件: D07077 D07077 💬 |
EDNRA 1件: EDNRA 💬 |
Calcium signaling pathway 7件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 7件: 51, 84, 85, 86, 88, 210, 211 💬 |
22 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 1件: 85 💬 |
23 |
Art-123 |
- |
- |
- |
- |
085 1件: 85 💬 |
24 |
Atezolizumab |
Atezolizumab |
1件: D10773 D10773 💬 |
CD274 1件: CD274 💬 |
Cell adhesion molecules 2件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer |
085 1件: 85 💬 |
25 |
Autoantibody reductive therapy |
- |
- |
- |
- |
085 1件: 85 💬 |
26 |
Autologous adipose derived mscs (admscs) |
- |
- |
- |
- |
085 1件: 85 💬 |
27 |
Autologous mesenchymal stem cells derived from bone marrow |
- |
- |
- |
- |
085 1件: 85 💬 |
28 |
Autologous stromal vascular fraction (svf) |
- |
- |
- |
- |
085 1件: 85 💬 |
29 |
Aviptadil |
Aviptadil |
- |
- |
- |
049 4件: 49, 51, 85, 86 💬 |
30 |
Aviptadil, 66 microgram/ml |
Aviptadil |
- |
- |
- |
085 1件: 85 💬 |
31 |
Azapred |
- |
- |
- |
- |
085 1件: 85 💬 |
32 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
33 |
Azathioprine/prednisone |
Azathioprine |
3件: D00238 D00238, D00473 D00473, D03033 D03033 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
085 1件: 85 💬 |
34 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
35 |
Bardoxolone |
Bardoxolone |
1件: D09584 D09584 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
36 |
Bardoxolone methyl |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 7件: 66, 67, 84, 85, 86, 218, 222 💬 |
37 |
Bbt-877, multiple doses |
- |
- |
- |
- |
085 1件: 85 💬 |
38 |
Bbt-877, single dose |
- |
- |
- |
- |
085 1件: 85 💬 |
39 |
Beclometasone dipropionate |
Beclomethasone dipropionate |
2件: D00689 D00689, D07495 D07495 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
085 2件: 85, 97 💬 |
40 |
Bevacizumab |
Bevacizumab |
1件: D06409 D06409 💬 |
VEGFA 1件: VEGFA 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway |
013 9件: 13, 34, 85, 86, 87, 89, 227, 280, 331 💬 |
41 |
Bg00011 |
- |
- |
- |
- |
085 1件: 85 💬 |
42 |
Bi 1015550 |
- |
- |
- |
- |
085 1件: 85 💬 |
43 |
Bibf 1120 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
44 |
Bibf 1120 es |
- |
- |
- |
- |
085 1件: 85 💬 |
45 |
Bibf1120 |
- |
- |
- |
- |
085 1件: 85 💬 |
46 |
Bld-2660 |
- |
- |
- |
- |
085 1件: 85 💬 |
47 |
Blood sample collection |
- |
- |
- |
- |
085 1件: 85 💬 |
48 |
Bms-986020 |
BMS-986020 |
- |
- |
- |
051 2件: 51, 85 💬 |
49 |
Bms-986278 |
- |
- |
- |
- |
085 1件: 85 💬 |
50 |
Bone marrow mesenchymal stem cells |
- |
- |
- |
- |
085 1件: 85 💬 |
51 |
Bosentan |
Bosentan |
2件: D01227 D01227, D07538 D07538 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 11件: 13, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬 |
52 |
C21 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
53 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
54 |
Carbon monoxide |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
085 3件: 85, 86, 298 💬 |
55 |
Carboplatin |
Carboplatin |
1件: D01363 D01363 💬 |
- |
- |
028 4件: 28, 34, 60, 85 💬 |
56 |
Caveolin-1-scaffolding-protein-derived peptide (lti-03) |
- |
- |
- |
- |
085 1件: 85 💬 |
57 |
Cbdca |
Carboplatin |
1件: D01363 D01363 💬 |
- |
- |
085 1件: 85 💬 |
58 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
59 |
Cc-90001 |
- |
- |
- |
- |
085 1件: 85 💬 |
60 |
Cc-930 |
- |
- |
- |
- |
085 1件: 85 💬 |
61 |
Cd3/cd19 negative hematopoietic stem cells |
- |
- |
- |
- |
085 1件: 85 💬 |
62 |
Cnc |
- |
- |
- |
- |
085 1件: 85 💬 |
63 |
Cnto 888 1 mg/kg |
- |
- |
- |
- |
085 1件: 85 💬 |
64 |
Cnto 888 15 mg/kg |
- |
- |
- |
- |
085 1件: 85 💬 |
65 |
Cnto 888 5 mg/kg |
- |
- |
- |
- |
085 1件: 85 💬 |
66 |
Cnto888 |
- |
- |
- |
- |
085 1件: 85 💬 |
67 |
Co |
- |
- |
- |
- |
006 5件: 6 , 13, 53, 70, 85 💬 |
68 |
Co-trimoxazole |
- |
- |
- |
- |
085 1件: 85 💬 |
69 |
Combined plasma exchange (pex), rituximab, and corticosteroids |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
085 1件: 85 💬 |
70 |
Compound 21 |
- |
- |
- |
- |
085 1件: 85 💬 |
71 |
Corticosteroid (prednisolone) |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
085 1件: 85 💬 |
72 |
Cotrimoxazole |
- |
- |
- |
- |
085 2件: 85, 97 💬 |
73 |
Cravit |
- |
- |
- |
- |
085 1件: 85 💬 |
74 |
Cromoglicate |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
75 |
Cromoglicato disodico |
- |
- |
- |
- |
085 1件: 85 💬 |
76 |
Cromoglycate |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
77 |
Cromolyn |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
002 3件: 2 , 85, 98 💬 |
78 |
Cromolyn sodio (cromoglicato disodico, dscg) |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
79 |
Cromolyn sodium |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
80 |
Cromolyn sodium [disodium cromoglycate] |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
81 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
82 |
Cyclosphamine |
- |
- |
- |
- |
085 1件: 85 💬 |
83 |
Cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
006 11件: 6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬 |
84 |
Dabigatran |
Dabigatran |
1件: D09707 D09707 💬 |
F2 1件: F2 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
051 4件: 51, 85, 91, 124 💬 |
85 |
Dasatinib |
Dasatinib |
2件: D03658 D03658, D06414 D06414 💬 |
ABL1 8件: ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia 74件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
051 2件: 51, 85 💬 |
86 |
Dasatinib + quercetin |
Dasatinib |
2件: D03658 D03658, D06414 D06414 💬 |
ABL1 8件: ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬 |
Acute myeloid leukemia 74件: Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection |
085 1件: 85 💬 |
87 |
Device: auto-titrating oxygen system |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
88 |
Device: centricyte 1000 |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
89 |
Device: mri |
- |
- |
- |
- |
070 3件: 70, 85, 278 💬 |
90 |
Device: oxymizer® compared to cnc |
- |
- |
- |
- |
085 1件: 85 💬 |
91 |
Dex284 |
- |
- |
- |
- |
085 1件: 85 💬 |
92 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
93 |
Diagnostic test: metabolomics |
- |
- |
- |
- |
085 1件: 85 💬 |
94 |
Diagnostic test: pet imaging |
- |
- |
- |
- |
085 1件: 85 💬 |
95 |
Disodium cromoglycate (dscg) |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
96 |
Disodium cromoglycate [cromolyn sodium] |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
97 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
98 |
Dpa |
- |
- |
- |
- |
002 4件: 2 , 6 , 13, 85 💬 |
99 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 9件: 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
100 |
Endobronchial infusion of adult mesenchymal stem cells |
- |
- |
- |
- |
085 1件: 85 💬 |
101 |
Endoxan |
- |
- |
- |
- |
013 7件: 13, 28, 43, 44, 85, 96, 222 💬 |
102 |
Epigallocatechin |
Epigallocatechin |
- |
- |
- |
008 5件: 8 , 13, 28, 85, 113 💬 |
103 |
Epigallocatechin-3-gallate (egcg) |
Epigallocatechin |
- |
- |
- |
028 2件: 28, 85 💬 |
104 |
Erivedge |
- |
- |
- |
- |
085 1件: 85 💬 |
105 |
Esbriet |
- |
- |
- |
- |
046 4件: 46, 51, 85, 228 💬 |
106 |
Esbriet® (pirfenidon) |
- |
- |
- |
- |
085 1件: 85 💬 |
107 |
Etanercept |
Etanercept |
1件: D00742 D00742 💬 |
LTA 2件: LTA, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
015 14件: 15, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬 |
108 |
Etoposide |
Etoposide |
2件: D00125 D00125, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
011 11件: 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
109 |
Ez-2053 |
- |
- |
- |
- |
085 2件: 85, 299 💬 |
110 |
Ez-2053 5mg/kg |
- |
- |
- |
- |
085 2件: 85, 299 💬 |
111 |
Fg-3019 |
- |
- |
- |
- |
085 3件: 85, 113, 222 💬 |
112 |
Fg-3019 10mg/ml in 10 ml vials |
- |
- |
- |
- |
085 1件: 85 💬 |
113 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
114 |
Fludeoxyglucose |
Fludeoxyglucose |
1件: D01843 D01843 💬 |
- |
- |
034 4件: 34, 84, 85, 88 💬 |
115 |
Fluimucil |
- |
- |
- |
- |
085 4件: 85, 94, 193, 298 💬 |
116 |
Fluimucil® 600 mg effervescent tablets |
- |
- |
- |
- |
085 1件: 85 💬 |
117 |
Fluorine (18f) fludeoxyglucose |
Fludeoxyglucose |
1件: D01843 D01843 💬 |
- |
- |
084 2件: 84, 85 💬 |
118 |
Formoterol |
Formoterol |
3件: D01373 D01373, D05277 D05277, D07990 D07990 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 3件: 85, 228, 299 💬 |
119 |
Formoterol fumarate dihydrate |
Formoterol |
3件: D01373 D01373, D05277 D05277, D07990 D07990 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
120 |
Fostair |
- |
- |
- |
- |
085 1件: 85 💬 |
121 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
122 |
G321605 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
123 |
G451990 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
124 |
Gallium68-dota-noc |
- |
- |
- |
- |
085 1件: 85 💬 |
125 |
Gbt440 |
- |
- |
- |
- |
085 1件: 85 💬 |
126 |
Gbt440 300 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
127 |
Gbt440 300 mg tablet |
- |
- |
- |
- |
085 1件: 85 💬 |
128 |
Gc1008 |
Fresolimumab |
1件: D09620 D09620 💬 |
TGFB1 3件: TGFB1, TGFB2, TGFB3 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 2件: 85, 222 💬 |
129 |
Gefapixant |
Gefapixant |
1件: D11349 D11349 💬 |
P2RX3 1件: P2RX3 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Taste transduction |
085 2件: 85, 226 💬 |
130 |
Gkt137831 |
- |
- |
- |
- |
085 2件: 85, 93 💬 |
131 |
Glpg1205 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
132 |
Glpg1690 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
133 |
Glpg1690 600 mg qd |
- |
- |
- |
- |
085 1件: 85 💬 |
134 |
Granulocyte colony stimulating factor |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 6件: 2 , 28, 36, 57, 65, 85 💬 |
135 |
Gs-6624 |
Simtuzumab |
- |
- |
- |
085 2件: 85, 94 💬 |
136 |
Gsk2126458 |
- |
- |
- |
- |
085 1件: 85 💬 |
137 |
Gsk3008348 |
- |
- |
- |
- |
085 1件: 85 💬 |
138 |
Gsk3008348 nebuliser solution |
- |
- |
- |
- |
085 1件: 85 💬 |
139 |
Hec 68498 |
- |
- |
- |
- |
085 1件: 85 💬 |
140 |
Hec585 |
- |
- |
- |
- |
085 1件: 85 💬 |
141 |
High dose bibf 1120 twice daily |
- |
- |
- |
- |
085 1件: 85 💬 |
142 |
Humanized anti-alpha v beta 6 mab |
- |
- |
- |
- |
085 1件: 85 💬 |
143 |
Hydroxyurea |
Hydroxyurea |
1件: D00341 D00341 💬 |
RRM2 1件: RRM2 💬 |
Drug metabolism - other enzymes 6件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway |
003 8件: 3 , 13, 19, 20, 65, 85, 86, 284 💬 |
144 |
Hyperoxia |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
145 |
Hyperpolarized 129 xenon gas comparing idiopathic pulmonary fibrosis (ipf) treatment |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
085 1件: 85 💬 |
146 |
Hyperpolarized 129-xenon gas |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
085 1件: 85 💬 |
147 |
Idl-2965 oral capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
148 |
Ifenprodil |
Ifenprodil |
1件: D08064 D08064 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
149 |
Iloprost |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 4件: 51, 84, 85, 86 💬 |
150 |
Iloprost inhalation solution (ventavis) |
Iloprost |
1件: D02721 D02721 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
085 2件: 85, 86 💬 |
151 |
Imatinib |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
013 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬 |
152 |
Imatinib mesylate (gleevec) |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
085 1件: 85 💬 |
153 |
Immukin |
- |
- |
- |
- |
085 1件: 85 💬 |
154 |
Inhaled carbon monoxide |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
085 1件: 85 💬 |
155 |
Inhaled nitric oxide |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
085 2件: 85, 86 💬 |
156 |
Inhaled nitric oxide - 30 mcg/kg ibw/hr |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
085 1件: 85 💬 |
157 |
Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
085 1件: 85 💬 |
158 |
Inhaled nitric oxide 75 mcg/kg ibw/hr |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
085 2件: 85, 86 💬 |
159 |
Inhaled td139 |
- |
- |
- |
- |
085 1件: 85 💬 |
160 |
Ino |
- |
- |
- |
- |
085 2件: 85, 86 💬 |
161 |
Inomax |
- |
- |
- |
- |
085 3件: 85, 294, 299 💬 |
162 |
Inomax 400ppm mol/mol inhalation gas |
- |
- |
- |
- |
085 2件: 85, 299 💬 |
163 |
Interferon alpha oral lozenge |
- |
- |
- |
- |
085 1件: 85 💬 |
164 |
Interferon gamma |
Interferon Gamma |
- |
- |
- |
018 8件: 18, 65, 85, 107, 228, 299, 301, 326 💬 |
165 |
Interferon gamma-1b |
Interferon Gamma |
1件: D00747 D00747 💬 |
IFNGR1 2件: IFNGR1, IFNGR2 💬 |
Chagas disease 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
018 7件: 18, 65, 85, 228, 299, 301, 326 💬 |
166 |
Interferon gamma-1b (actimmune) |
Interferon Gamma |
1件: D00747 D00747 💬 |
IFNGR1 2件: IFNGR1, IFNGR2 💬 |
Chagas disease 18件: Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis |
085 1件: 85 💬 |
167 |
Interferon-alpha lozenges |
- |
- |
- |
- |
085 1件: 85 💬 |
168 |
Interferon-gamma 1b |
- |
- |
- |
- |
085 1件: 85 💬 |
169 |
Intermediate dose bibf 1120 twice daily |
- |
- |
- |
- |
085 1件: 85 💬 |
170 |
Iw001 |
- |
- |
- |
- |
085 1件: 85 💬 |
171 |
Jaktinib dihydrochloride monohydrate 50mg bid and mimic tablets of jakitinib hydrochloride 75mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
172 |
Jaktinib dihydrochloride monohydrate 75mg bid and mimic tablets of jakitinib hydrochloride 50mg bid and acetylcysteine effervescent tablets |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
173 |
Jin-shui huan-xian granule |
- |
- |
- |
- |
085 1件: 85 💬 |
174 |
Kd025 |
- |
- |
- |
- |
085 1件: 85 💬 |
175 |
L - antineoplastic and immunomodulating agents |
- |
- |
- |
- |
085 1件: 85 💬 |
176 |
L01 - antineoplastic agents |
- |
- |
- |
- |
085 1件: 85 💬 |
177 |
L01x - other antineoplastic agents |
- |
- |
- |
- |
085 1件: 85 💬 |
178 |
L01xe - protein kinase inhibitors |
- |
- |
- |
- |
085 1件: 85 💬 |
179 |
L01xe31 |
- |
- |
- |
- |
085 1件: 85 💬 |
180 |
L01xe31 - nintedanib |
Nintedanib |
1件: D10481 D10481 💬 |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction 34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
085 1件: 85 💬 |
181 |
Lanreotide |
Lanreotide |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
182 |
Lanreotide acetate |
Acetate |
1件: D04666 D04666 💬 |
- |
- |
067 4件: 67, 73, 85, 298 💬 |
183 |
Lansoprazole |
Lansoprazole |
1件: D00355 D00355 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
063 7件: 63, 71, 85, 98, 166, 222, 299 💬 |
184 |
Lebrikizumab |
Lebrikizumab |
1件: D09633 D09633 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 1件: 85 💬 |
185 |
Letairis |
- |
- |
- |
- |
085 1件: 85 💬 |
186 |
Letairis 10 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
187 |
Letairis 5 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
188 |
Liberase enzyme (roche) |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
189 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
190 |
Low dose bibf 1120 twice daily |
- |
- |
- |
- |
085 1件: 85 💬 |
191 |
Low dose bibf1120 once daily |
- |
- |
- |
- |
085 1件: 85 💬 |
192 |
Lpa1 |
- |
- |
- |
- |
085 1件: 85 💬 |
193 |
Lung spheroid stem cells 100 million |
- |
- |
- |
- |
085 1件: 85 💬 |
194 |
Lung spheroid stem cells 200 million |
- |
- |
- |
- |
085 1件: 85 💬 |
195 |
Lung stem cells |
- |
- |
- |
- |
085 1件: 85 💬 |
196 |
Macitentan |
Macitentan |
1件: D10135 D10135 💬 |
EDNRA 2件: EDNRA, EDNRB 💬 |
Calcium signaling pathway 9件: Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 5件: 51, 85, 86, 88, 210 💬 |
197 |
Medical air |
Medical air |
- |
- |
- |
085 3件: 85, 86, 193 💬 |
198 |
Medical air (sham o2) |
Medical air |
- |
- |
- |
085 1件: 85 💬 |
199 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
200 |
Mg-s-2525 |
- |
- |
- |
- |
085 1件: 85 💬 |
201 |
Minocycline |
Minocycline |
2件: D00850 D00850, D05045 D05045 💬 |
- |
- |
002 13件: 2 , 6 , 8 , 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 💬 |
202 |
Monitor |
Methamidophos |
- |
- |
- |
002 18件: 2 , 11, 13, 19, 46, 49, 58, 65, 70, 85, 86, 98, 113, 118, 129, 298, 299, 300 💬 |
203 |
Montelukast |
Montelukast |
2件: D00529 D00529, D08229 D08229 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
013 5件: 13, 46, 85, 98, 228 💬 |
204 |
Morphine |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
036 5件: 36, 46, 70, 85, 86 💬 |
205 |
Morphine hydrochloride |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
085 1件: 85 💬 |
206 |
Morphine sulfate |
Morphine |
3件: D00842 D00842, D02271 D02271, D08233 D08233 💬 |
OPRM1 1件: OPRM1 💬 |
Estrogen signaling pathway 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction |
046 3件: 46, 85, 86 💬 |
207 |
Moxifloxacin |
Moxifloxacin |
2件: D00874 D00874, D08237 D08237 💬 |
- |
- |
002 8件: 2 , 6 , 46, 49, 85, 86, 240, 299 💬 |
208 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
209 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
210 |
N-acetyl cysteine |
Cysteine |
2件: D00026 D00026, D02326 D02326 💬 |
- |
- |
013 7件: 13, 19, 34, 85, 88, 296, 310 💬 |
211 |
N-acetylcysteine |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 10件: 6 , 13, 19, 20, 49, 58, 85, 111, 164, 299 💬 |
212 |
N-acetylcysteine, (nac) |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
085 1件: 85 💬 |
213 |
Na |
- |
- |
- |
- |
036 3件: 36, 46, 85 💬 |
214 |
Nac |
- |
- |
- |
- |
034 5件: 34, 51, 85, 90, 299 💬 |
215 |
Nalbuphine |
Nalbuphine |
2件: D00843 D00843, D08246 D08246 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
216 |
Nalbuphine er |
Nalbuphine |
2件: D00843 D00843, D08246 D08246 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
217 |
Nalbuphine extended-realease (er) tablets |
Nalbuphine |
2件: D00843 D00843, D08246 D08246 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
218 |
Nalbuphine extended-release (er) tablets |
Nalbuphine |
2件: D00843 D00843, D08246 D08246 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
219 |
Nalbuphine hydrochloride |
Nalbuphine |
2件: D00843 D00843, D08246 D08246 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
220 |
Nandrolone |
Nandrolone |
1件: D08250 D08250 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
060 2件: 60, 85 💬 |
221 |
Nandrolone decanoate |
Nandrolone |
2件: D00955 D00955, D08250 D08250 💬 |
AR 1件: AR 💬 |
Oocyte meiosis 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer |
060 2件: 60, 85 💬 |
222 |
Nd-l02-s0201 |
- |
- |
- |
- |
085 1件: 85 💬 |
223 |
Nd-l02-s0201 for injection |
- |
- |
- |
- |
085 1件: 85 💬 |
224 |
Nintedanib |
Nintedanib |
1件: D10481 D10481 💬 |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction 34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
051 5件: 51, 85, 89, 227, 228 💬 |
225 |
Nitric oxide |
Nitric Oxide |
1件: D00074 D00074 💬 |
- |
- |
046 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬 |
226 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
227 |
None |
- |
- |
- |
- |
046 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
228 |
Octreotide |
Octreotide |
2件: D00442 D00442, D06495 D06495 💬 |
SSTR2 1件: SSTR2 💬 |
Gastric acid secretion 4件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
067 7件: 67, 75, 84, 85, 89, 193, 227 💬 |
229 |
Ofev |
- |
- |
- |
- |
051 5件: 51, 85, 89, 227, 228 💬 |
230 |
Ofev 100 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
231 |
Ofev 150 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
232 |
Ofev® |
- |
- |
- |
- |
085 1件: 85 💬 |
233 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
234 |
Omeprazole (uk licensed generic product) |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
085 1件: 85 💬 |
235 |
Orin1001 |
- |
- |
- |
- |
085 1件: 85 💬 |
236 |
Other: 60% oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
237 |
Other: control |
- |
- |
- |
- |
006 8件: 6 , 19, 70, 75, 85, 97, 162, 193 💬 |
238 |
Other: cough monitor |
Methamidophos |
- |
- |
- |
085 1件: 85 💬 |
239 |
Other: medical air |
Medical air |
- |
- |
- |
085 1件: 85 💬 |
240 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 1件: 85 💬 |
241 |
Other: oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
242 |
Other: oxygen (2liter/min) |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
243 |
Other: oxygen (4liter/min) |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
244 |
Other: pulmonary rehabilitation program |
- |
- |
- |
- |
085 1件: 85 💬 |
245 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
246 |
Other: untreated cohort |
- |
- |
- |
- |
085 1件: 85 💬 |
247 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
248 |
Oxygen 40 % |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
085 1件: 85 💬 |
249 |
Pa101 |
- |
- |
- |
- |
085 1件: 85 💬 |
250 |
Paclitaxel |
Paclitaxel |
2件: D00491 D00491, D05333 D05333 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
046 2件: 46, 85 💬 |
251 |
Pamrevlumab |
Pamrevlumab |
1件: D10969 D10969 💬 |
CCN2 1件: CCN2 💬 |
Apelin signaling pathway 2件: Apelin signaling pathway, Hippo signaling pathway |
085 2件: 85, 113 💬 |
252 |
Pbi4050 |
- |
- |
- |
- |
085 2件: 85, 299 💬 |
253 |
Pd00377 na-salt |
- |
- |
- |
- |
085 1件: 85 💬 |
254 |
Pet/ct using pet ligands [f-18]fdg and [f-18]dpa-714 |
- |
- |
- |
- |
085 1件: 85 💬 |
255 |
Pir, s-7701 |
- |
- |
- |
- |
085 1件: 85 💬 |
256 |
Pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
034 10件: 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬 |
257 |
Pirfenidone and nintedanib |
Nintedanib |
2件: D01583 D01583, D10481 D10481 💬 |
CCL2 14件: CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 104件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
258 |
Pirfenidone or nintedanib |
Nintedanib |
2件: D01583 D01583, D10481 D10481 💬 |
CCL2 14件: CCL2, FGFR1, FGFR2, FGFR3, FLT1, FLT4, IL10, IL1A, IL1B, IL6, KDR, PDGFRA, PDGFRB, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 104件: AGE-RAGE signaling pathway in diabetic complications, Adherens junction, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemokine signaling pathway, Choline metabolism in cancer, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, Melanoma, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Phospholipase D signaling pathway, Prion disease, Prostate cancer, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, VEGF signaling pathway, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
259 |
Pirfenidoneone |
- |
- |
- |
- |
085 1件: 85 💬 |
260 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
261 |
Pln-74809 |
- |
- |
- |
- |
085 2件: 85, 94 💬 |
262 |
Pln-74809-000 |
- |
- |
- |
- |
085 1件: 85 💬 |
263 |
Pomalidomide |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
028 6件: 28, 34, 51, 85, 227, 331 💬 |
264 |
Pomalidomide (cc-4047 |
Pomalidomide |
1件: D08976 D08976 💬 |
IL6 2件: IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 78件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
265 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
266 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
267 |
Privigen 100mg/ml |
- |
- |
- |
- |
085 1件: 85 💬 |
268 |
Prm-151 |
PRM-151 |
- |
- |
- |
085 1件: 85 💬 |
269 |
Procedure: iv deployment of csvf in sterile normal saline iv solution |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
270 |
Procedure: microcannula harvest adipose derived tissue stromal vascular fraction (tsvf) |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
271 |
Pzn 8881655(rochepharma ag) |
- |
- |
- |
- |
085 1件: 85 💬 |
272 |
Qax576 |
- |
- |
- |
- |
051 4件: 51, 85, 96, 98 💬 |
273 |
Quercetin |
Quercetin |
- |
- |
- |
084 5件: 84, 85, 192, 285, 299 💬 |
274 |
Radiation: fdg pet scan |
- |
- |
- |
- |
085 1件: 85 💬 |
275 |
Radiation: gsk26346763: ([18f]-fba-a20fmdv2) iv infusion |
- |
- |
- |
- |
085 1件: 85 💬 |
276 |
Radiation: knottin tracer |
- |
- |
- |
- |
085 1件: 85 💬 |
277 |
Remicade |
- |
- |
- |
- |
040 9件: 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
278 |
Revatio |
- |
- |
- |
- |
085 3件: 85, 86, 113 💬 |
279 |
Revatio 20 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
280 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
281 |
Rixathon 500 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
282 |
Ro 47-0203 |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
283 |
Ro0220912 |
- |
- |
- |
- |
085 1件: 85 💬 |
284 |
Ro0280296 |
- |
- |
- |
- |
085 1件: 85 💬 |
285 |
Ro5490255 |
- |
- |
- |
- |
085 1件: 85 💬 |
286 |
Ro5490255/f01-02 |
- |
- |
- |
- |
085 1件: 85 💬 |
287 |
Rvt-1601 |
- |
- |
- |
- |
085 1件: 85 💬 |
288 |
Rvt-1601 (formerly, pa101b) |
- |
- |
- |
- |
085 1件: 85 💬 |
289 |
Salbutamol |
Salbutamol |
1件: D02147 D02147 💬 |
ADRB2 1件: ADRB2 💬 |
Adrenergic signaling in cardiomyocytes 8件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
003 9件: 3 , 11, 49, 85, 86, 111, 228, 256, 299 💬 |
290 |
Sar156597 |
- |
- |
- |
- |
051 2件: 51, 85 💬 |
291 |
Saracatinab |
- |
- |
- |
- |
085 1件: 85 💬 |
292 |
Septrin |
- |
- |
- |
- |
085 1件: 85 💬 |
293 |
Sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
006 17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬 |
294 |
Sildenafil (50 mg) |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
295 |
Sildenafil and losartan |
Losartan |
4件: D00357 D00357, D02229 D02229, D08146 D08146, D08514 D08514 💬 |
AGTR1 2件: AGTR1, PDE5A 💬 |
AGE-RAGE signaling pathway in diabetic complications 18件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Purine metabolism, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
085 1件: 85 💬 |
296 |
Sildenafil citrate |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
051 4件: 51, 85, 86, 225 💬 |
297 |
Simtuzumab |
Simtuzumab |
- |
- |
- |
085 2件: 85, 94 💬 |
298 |
Sirolimus |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 35件: 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
299 |
Sivelestat |
Sivelestat |
1件: D03788 D03788 💬 |
ELANE 1件: ELANE 💬 |
Neutrophil extracellular trap formation 3件: Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 3件: 13, 85, 96 💬 |
300 |
Sm04646 |
- |
- |
- |
- |
085 1件: 85 💬 |
301 |
Sodium cromoglicate |
Cromoglicic acid |
2件: D00526 D00526, D07753 D07753 💬 |
- |
- |
085 1件: 85 💬 |
302 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
303 |
Standard steroid treatment |
- |
- |
- |
- |
085 1件: 85 💬 |
304 |
Sterile normal saline for intravenous use |
- |
- |
- |
- |
085 2件: 85, 229 💬 |
305 |
Sub-study: nintedanib |
Nintedanib |
1件: D10481 D10481 💬 |
FGFR1 8件: FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 |
Adherens junction 34件: Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway |
085 1件: 85 💬 |
306 |
Sub-study: pirfenidone |
Pirfenidone |
1件: D01583 D01583 💬 |
CCL2 6件: CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 82件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 1件: 85 💬 |
307 |
Sulfamethoxazole |
Sulfamethoxazole |
1件: D00447 D00447 💬 |
- |
- |
044 4件: 44, 49, 85, 299 💬 |
308 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
309 |
Sulphamethoxazole |
Sulfamethoxazole |
1件: D00447 D00447 💬 |
- |
- |
085 1件: 85 💬 |
310 |
Symbicort |
- |
- |
- |
- |
085 2件: 85, 228 💬 |
311 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
312 |
Tbc |
- |
- |
- |
- |
085 3件: 85, 94, 96 💬 |
313 |
Td-1058 |
- |
- |
- |
- |
085 1件: 85 💬 |
314 |
Td139 |
- |
- |
- |
- |
085 1件: 85 💬 |
315 |
Tetrandrine |
Tetrandrine |
- |
- |
- |
046 2件: 46, 85 💬 |
316 |
Tetrathiomolybdate |
Tetrathiomolybdate |
- |
- |
- |
085 3件: 85, 93, 171 💬 |
317 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
318 |
Thalidomide pharmion |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 3件: 85, 96, 97 💬 |
319 |
The standard steroid treatment, plasma exchange and rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
085 1件: 85 💬 |
320 |
Thiotepa |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
013 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
321 |
Thrombomodulin alfa |
Thrombomodulin Alfa |
1件: D06410 D06410 💬 |
F2 1件: F2 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton |
085 1件: 85 💬 |
322 |
Tiotropium |
Tiotropium |
- |
- |
- |
055 3件: 55, 85, 299 💬 |
323 |
Tipelukast |
Tipelukast |
1件: D06659 D06659 💬 |
CYSLTR1 1件: CYSLTR1 💬 |
Calcium signaling pathway 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction |
085 1件: 85 💬 |
324 |
Tnx-650, rhumab anti-il13, ail-13, milr1444a |
- |
- |
- |
- |
085 1件: 85 💬 |
325 |
Tr0311 |
- |
- |
- |
- |
085 1件: 85 💬 |
326 |
Tracleer |
- |
- |
- |
- |
013 8件: 13, 51, 84, 85, 86, 88, 210, 211 💬 |
327 |
Traditional chinese medicine formulation |
- |
- |
- |
- |
085 1件: 85 💬 |
328 |
Tralokinumab |
Tralokinumab |
1件: D09979 D09979 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 2件: 85, 97 💬 |
329 |
Tralokinumab cohort 1 |
Tralokinumab |
1件: D09979 D09979 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 1件: 85 💬 |
330 |
Tralokinumab cohort 2 |
Tralokinumab |
1件: D09979 D09979 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 1件: 85 💬 |
331 |
Tralokinumab is a human recombinant monoclonal antibody (mab) of the subclass that specifically binds human il-13, blocking interactions with the il-13 receptor |
Tralokinumab |
1件: D09979 D09979 💬 |
IL13 1件: IL13 💬 |
Asthma 8件: Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation |
085 1件: 85 💬 |
332 |
Treatment as usual (tau) |
- |
- |
- |
- |
085 1件: 85 💬 |
333 |
Treprostinil |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
051 6件: 51, 84, 85, 86, 88, 210 💬 |
334 |
Treprostinil sodium for inhalation |
Treprostinil |
1件: D06213 D06213 💬 |
PTGIR 1件: PTGIR 💬 |
Neuroactive ligand-receptor interaction 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
085 1件: 85 💬 |
335 |
Trimethoprim |
Trimethoprim |
2件: D00145 D00145, D06236 D06236 💬 |
- |
- |
036 6件: 36, 44, 49, 60, 85, 299 💬 |
336 |
Trk-250 |
- |
- |
- |
- |
085 1件: 85 💬 |
337 |
Uromitexan |
- |
- |
- |
- |
085 1件: 85 💬 |
338 |
Valganciclovir |
Valganciclovir |
1件: D02495 D02495 💬 |
- |
- |
028 6件: 28, 60, 85, 97, 299, 331 💬 |
339 |
Vasoactive intestinal peptide |
- |
- |
- |
- |
085 1件: 85 💬 |
340 |
Vay736 |
- |
- |
- |
- |
013 7件: 13, 35, 46, 49, 53, 85, 95 💬 |
341 |
Vismodegib |
Vismodegib |
1件: D09992 D09992 💬 |
SMO 1件: SMO 💬 |
Axon guidance 5件: Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer |
085 1件: 85 💬 |
342 |
Volibris |
- |
- |
- |
- |
051 4件: 51, 85, 86, 88 💬 |
343 |
Vrp700 |
- |
- |
- |
- |
085 1件: 85 💬 |
344 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
345 |
Xenon |
Xenon |
2件: D01901 D01901, D06339 D06339 💬 |
- |
- |
022 4件: 22, 85, 228, 299 💬 |
346 |
Zileuton |
Zileuton |
1件: D00414 D00414 💬 |
ALOX5 1件: ALOX5 💬 |
Arachidonic acid metabolism 6件: Arachidonic acid metabolism, Fc epsilon RI signaling pathway, Metabolic pathways, Ovarian steroidogenesis, Serotonergic synapse, Toxoplasmosis |
085 3件: 85, 160, 164 💬 |
347 |
Ziritaxestat |
Ziritaxestat |
1件: D11844 D11844 💬 |
ENPP2 1件: ENPP2 💬 |
Ether lipid metabolism 1件: Ether lipid metabolism |
051 2件: 51, 85 💬 |
348 |
Zl-2102 |
- |
- |
- |
- |
085 1件: 85 💬 |
349 |
Zsp1603 12.5 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
350 |
Zsp1603 25 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
351 |
Zsp1603 50 mg |
- |
- |
- |
- |
085 1件: 85 💬 |
352 |
Zsp1603 7.5 mg |
- |
- |
- |
- |
085 1件: 85 💬 |